Adjuvant SOX chemotherapy versus concurrent chemoradiotherapy after D2 radical resection of locally advanced esophagogastric junction (EGJ) adenocarcinoma: study protocol for a randomized phase III trial (ARTEG).
Jinwen ShenXiu ZhuYian DuYuan ZhuPengfei YuLitao YangZhiyuan XuLing HuangYunli ZhangYanqiang ZhangLuying LiuXiang-Dong ChengPublished in: Trials (2021)
ClinicalTrials.gov NCT03973008 . Registered on 1 June 2019 (retrospectively registered), URL: https://clinicaltrials.gov/ct2/show/NCT03973008?term=NCT03973008&draw=2&rank=1.
Keyphrases
- locally advanced
- phase iii
- rectal cancer
- open label
- neoadjuvant chemotherapy
- squamous cell carcinoma
- clinical trial
- phase ii study
- radiation therapy
- phase ii
- double blind
- early stage
- placebo controlled
- stem cells
- transcription factor
- preterm infants
- image quality
- contrast enhanced
- randomized controlled trial
- dual energy
- gestational age
- positron emission tomography
- lymph node
- pet ct